Blog posts
Results of you search request.
Results of you search request.
If you manage a pharma trademark portfolio in-house, you already know the ECJ’s “BMS” criteria: repackaging is only lawful if objectively necessary, and you must
Not necessarily. In its judgment of 28 April 2026 (3 Ni 7/24 (EP)), the German Federal Patent Court dismissed in its entirety a nullity action
For innovative pharmaceutical companies, that question can determine the fate of a blockbuster. In T 0592/24, the EPO Boards of Appeal provided one of their
In a recent case handled by our firm, we observed a parallel importer attempting to bypass the established legal framework by repackaging a client’s pharmaceutical
The German Federal Patent Court’s landmark Safinamide ruling (14 W (pat) 23/24) provides a strategic blueprint for pharma industry, confirming that single-agent SPCs (Supplementary protection
In a pivotal decision (3 Ni 6/24 (EP)), the German Federal Patent Court (BPatG) invalidated a patent for a cancer therapy due to a “structural
The German Federal Court of Justice (BGH) recently issued a landmark decision (X ZB 3/25) on February 25, 2026, clarifying the requirements for the disclosure
The German Federal Court of Justice (BGH) has recently overturned a lower court decision, confirming the validity of a patent for Fampridine-SR used to increase
Although some time has passed since the “GALENPHARMA” decision presented at the PTMG (Pharmaceutical Trade Marks Group) Spring Meeting in Munich, it contains important insights into how trademarks
+49 351 470 37 - 0
info@ku-patent.de
https://ku-patent.de/
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information